<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:ms="urn:schemas-microsoft-com:xslt" xmlns:dt="urn:schemas-microsoft-com:datatypes">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <style type="text/css">
					body { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					a {
					color: #039;
					text-decoration: none;
					}
					
					.block {
					margin: 0 3em 1em;
					}

					p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					padding: 0;
					text-align: left;
					}

					ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					table-layout: auto;
					}

					th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					div#wrapper { width: 650px; }

					div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					div#Sections { width: 650px; }

					div#Sections table { page-break-inside: avoid; }

					div#Codebook {
					width: 650px;
					page-break-after: always;
					}

					div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					div#References {
					page-break-after: always;
					width: 650px;
					}

					div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					position: relative;
					width: 600px;
					}

					span.file-size { color: gray; }

					.pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</style>
    <style type="text/css" media="print">
					div#toc { display: none; }
				</style>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="Keywords" content="Surveys,Data Collection,NCHS,NHANES,National Health and Nutrition Examination Survey,data,documentation,Albumin &amp; Creatinine - Urine" />
    <meta name="DC.Subject" content="NHANES 2011-2012: Albumin &amp; Creatinine - Urine Data Documentation" />
    <meta name="DC.Language" scheme="ISO 639-2" content="eng" />
    <link rel="Prev" Title="NHANES 2011-2012 Laboratory page" href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory&amp;CycleBeginYear=2011">
      <title>
						NHANES 2011-2012:
						Albumin &amp; Creatinine - Urine Data Documentation, Codebook, and Frequencies</title>
    </link>
  </head>
  <body>
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <div id="CodebookLinks">
              <ul>
                <li>
                  <a href="#SEQN">SEQN - Respondent sequence number</a>
                </li>
                <li>
                  <a href="#URXUMA">URXUMA   - Albumin, urine (ug/mL)</a>
                </li>
                <li>
                  <a href="#URXUMS">URXUMS   - Albumin, urine (mg/L)</a>
                </li>
                <li>
                  <a href="#URXUCR">URXUCR   - Creatinine, urine (mg/dL)</a>
                </li>
                <li>
                  <a href="#URXCRS">URXCRS   - Creatinine, urine (umol/L)</a>
                </li>
                <li>
                  <a href="#URDACT">URDACT   - Albumin creatinine ratio (mg/g)</a>
                </li>
              </ul>
            </div>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader" xmlns="">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2011-2012 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Albumin &amp; Creatinine - Urine (ALB_CR_G)
			</h3>
        <h4>
				Data File: ALB_CR_G.xpt
			</h4>
        <h5 class="left">
				First Published:
				September 2013</h5>
        <h5 class="right">
				Last Revised:
				September 2016</h5>
      </div>
      <div id="Sections" xmlns="">
        <h2 id="Component_Description">Component Description</h2>
        <div class="block"><p>Urinary albumin and urinary creatinine are measured in a random urine collected in the MEC. </p></div>
        <h2 id="Eligible_Sample">Eligible Sample</h2>
        <div class="block"><p>Participants aged 6 years and older were eligible to be tested.</p></div>
        <h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2>
        <div class="block"><p>Urine specimens are processed, stored and shipped to University of Minnesota, Minneapolis, MN for analysis.</p>
<p><strong>Urinary Albumin <br />
</strong>A solid-phase fluorescent immunoassay for the measurement of human urinary albumin is described by Chavers et al. (Chavers, BM, Kidney Int. 1984; 25:576&ndash;578). The fluorescent immunoassay is a non-competitive, double-antibody method for the determination of human albumin in urine. Antibody to human albumin is covalently attached to derivatized polyacrylamide beads. The solid-phase antibody is reacted with a urine specimen, and the urine albumin-antigen complexes with the solid-phase antibody. This complex then reacts with fluorescein-labeled antibody. The unattached fluorescent antibody is then removed by washing during centrifugation. The fluorescence of the stable solid-phase antibody complex is determined with a fluorometer; the fluorescence is directly proportional to the amount of urine albumin present. The standard curve is 0.5&ndash;20 &mu;g/mL of albumin.</p>
<p>Results of the fluorescent immunoassay (FIA) are reproducible, and the test is accurate and sensitive for the detection of human urinary albumin excretion. It is especially useful for the measurement of low levels of urinary albumin not detectable by dipstick methods. The FIA assay resembles the radio-immunoassay (RIA) in technique and sensitivity without the potential health hazards associated with the handling of isotopes in the laboratory (Chavers, BM, Kidney Int. 1984; 25:576&ndash;578).&nbsp;</p>
<p><strong>Urinary Creatinine using the Roche/Hitachi Modular P Chemistry Analyzer</strong> <br />
In this enzymatic method creatinine is converted to creatine under the activity of creatininase. Creatine is then acted upon by creatinase to form sarcosine and urea. Sarcosine oxidase converts sarcosine to glycine and hydrogen peroxide, and the hydrogen peroxide reacts with a chromophore in the presence of peroxidase to produce a colored product that is measured at 546 nm (secondary wavelength = 700 nm). This is an endpoint reaction that agrees well with recognized HPLC methods, and it has the advantage over Jaffe picric acid-based methods that are susceptible to interferences from non-creatinine chromogens. <br />
<br />
There were no changes (from the previous 2 years of NHANES) in the laboratories performing the analyses. </p>
<p>Detailed instructions on specimen collection and processing can be found in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). </p></div>
        <h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2>
        <div class="block"><p>The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.</p>
<p>URDACT, the urine albumin/creatinine ratio was created in this data file:</p>
<p>The random urine albumin (URXUMA) in ug/mL and urine creatinine (URXUCR) in mg/dL were converted to the albumin/creatinine ratio (URDACT) in mg/g:</p>
<p><span style="text-decoration: underline;">URDACT = URXUMA/URXUCR x 100, round to .01</span></p></div>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2>
        <div class="block"><p>The NHANES quality control and quality assurance protocols (QA/QC) meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). </p></div>
        <h2 id="Analytic_Notes">Analytic Notes</h2>
        <div class="block"><p>Refer to the 2011-2012 <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2011">Laboratory Data Overview</a> for general information on NHANES laboratory data.</p>
<p>The analysis of NHANES 2011-2012 laboratory data must be conducted using the appropriate survey design and demographic variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2011">NHANES 2011-2012 Demographics File</a> contains demographic data, health indicators, and other related information collected during household interviews as well as the sample weight variables. The <a href="https://wwwn.cdc.gov/nchs/nhanes/2011-2012/fastqx_g.htm">Fasting Questionnaire File</a> includes auxiliary information such as fasting status, the time of venipuncture, and the conditions precluding venipuncture. The demographics and fasting questionnaire files may be linked to the laboratory data file using the unique survey participant identifier (i.e., SEQN). </p>
<p>Exam sample weights should be used for analyses. Please refer to the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic Guidelines</a> and the on-line NHANES&nbsp;<a href="https://www.cdc.gov/nchs/tutorials/" target="_blank">Tutorial</a>&nbsp; for further details on the use of sample weights and other analytic issues.</p></div>
      </div>
      <div id="References" xmlns="">
        <h2>References</h2>
        <ul>
          <li><p style="margin: 0in 0in 0pt;" class="MsoNormal">Burtis,CA, Ashwood, EA, Bruns, DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnosis. Elsevier Inc., 2006.<o:p></o:p></p>.</li>
          <li><p style="margin: 0in 0in 0pt;" class="MsoNormal">NHANES Laboratory Procedural Manual. Section 5: Urine Specimen Collection and Processing, https://wwwn.cdc.gov/nchs/data/nhanes/2009-2010/manuals/lab.pdf<o:p></o:p></p>
NHANES home urine collection manual. Available from: <a href="http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/HomeUrine.pdf">http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/HomeUrine.pdf</a></li>
          <li>Chavers BM, Simonson J, Michael AF. A solid-phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int. 1984;25:576&ndash;578.</li>
          <li>Creatinine Measurement Module Operating and Service Instructions, Beckman ASTRA. Brea (CA): Beckman Instruments, Inc., 1979.</li>
          <li>Kaplan LA, Pesce AJ, editors, Clinical Chemistry Theory, Analysis and Correlation. St. Louis: CV Mosby Company, 1984:416&ndash;1261.</li>
          <li>Maintenance Guide, Beckman ASTRA. Brea (CA): Beckman Instruments, Inc., 1982.</li>
          <li>National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Table 14: Prevalence of Stages of Chronic Kidney Disease and Levels of Kidney Function in the US. Am J Kidney Dis 39:S1-S266, 2002 (suppl 1).</li>
          <li>Operating and Service Instructions, Beckman ASTRA. Brea (CA): Beckman Instruments, Inc., 1986.</li>
          <li>Tietz NW, editor, Textbook of Clinical Chemistry. Philadelphia: WB Saunders Company, 1986;775&ndash;1392.</li>
        </ul>
      </div>
      <div id="Codebook" xmlns="">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="URXUMA">URXUMA   - Albumin, urine (ug/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">URXUMA  </dd>
            <dt>SAS Label: </dt>
            <dd>Albumin, urine (ug/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Albumin, urine (ug/mL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="URXUMS">URXUMS   - Albumin, urine (mg/L)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">URXUMS  </dd>
            <dt>SAS Label: </dt>
            <dd>Albumin, urine (mg/L)</dd>
            <dt>English Text: </dt>
            <dd class="info">Albumin, urine (mg/L)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="URXUCR">URXUCR   - Creatinine, urine (mg/dL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">URXUCR  </dd>
            <dt>SAS Label: </dt>
            <dd>Creatinine, urine (mg/dL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Creatinine, urine (mg/dL)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="URXCRS">URXCRS   - Creatinine, urine (umol/L)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">URXCRS  </dd>
            <dt>SAS Label: </dt>
            <dd>Creatinine, urine (umol/L)</dd>
            <dt>English Text: </dt>
            <dd class="info">Creatinine, urine (umol/L)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="URDACT">URDACT   - Albumin creatinine ratio (mg/g)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">URDACT  </dd>
            <dt>SAS Label: </dt>
            <dd>Albumin creatinine ratio (mg/g)</dd>
            <dt>English Text: </dt>
            <dd class="info">Albumin creatinine ratio (mg/g)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
      </div>
    </div>
  </body>
</html>